Valora Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 8

Valora Therapeutics General Information

Description

Operator of a pre-clinical stage biopharmaceutical company based in San Diego, California. The company specializes in the development of a new biological drug that enables the engineering of chimeric antibodies to unlock new mechanisms of immune signaling and activity, providing healthcare industry with transformative therapies in oncology and immune diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)

Valora Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valora Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 12-Feb-2026 Completed Startup
1. Seed Round 20-Nov-2024 Completed Pre-Clinical Trials
To view Valora Therapeutics’s complete valuation and funding history, request access »

Valora Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Valora Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Valora Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valora Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Category Ventures Venture Capital Minority
28 Capital Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Avalon Bioventures Venture Capital Minority
Bregua Corporation Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Valora Therapeutics FAQs

  • When was Valora Therapeutics founded?

    Valora Therapeutics was founded in 2023.

  • Where is Valora Therapeutics headquartered?

    Valora Therapeutics is headquartered in San Diego, CA.

  • What is the size of Valora Therapeutics?

    Valora Therapeutics has 6 total employees.

  • What industry is Valora Therapeutics in?

    Valora Therapeutics’s primary industry is Drug Discovery.

  • Is Valora Therapeutics a private or public company?

    Valora Therapeutics is a Private company.

  • What is Valora Therapeutics’s current revenue?

    The current revenue for Valora Therapeutics is .

  • How much funding has Valora Therapeutics raised over time?

    Valora Therapeutics has raised $30M.

  • Who are Valora Therapeutics’s investors?

    Category Ventures, 28 Capital, Alexandria Venture Investments, Avalon Bioventures, and Bregua Corporation are 5 of 8 investors who have invested in Valora Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process